Insulin For Life Usa Incorporated

Open & Accessible
Public Charity
Gainesville, FloridaMediumEIN: 460771608
Health CharitiesHospitals and ClinicsChronic Illness Support GroupsInternational Relief AgenciesHuman Services

Insulin for Life USA (EIN 46-0771608) is a Gainesville, FL-based 501(c)(3) that collects unopened, in-date insulin and diabetes supplies and redistributes them free of charge to licensed healthcare providers domestically and internationally. The site states IFL USA is licensed by the State of Florida to receive and distribute medications and provides donation, shipping, and contact information.

Source: Website · Mar 2026

Ideal Applicant

Licensed healthcare providers, clinics, hospital diabetes centers, or nonprofit programs that distribute insulin or diabetes supplies and can demonstrate operational capacity to receive and use donated medications.

Good Fit

  • Is a licensed medical provider or clinic able to accept and distribute insulin/supplies.
  • Has a track record serving people with diabetes or operating a diabetes clinic or program.
  • Can demonstrate clear logistics and compliance for receiving/redistributing medications.
  • Is located in the U.S. (foundation funds multiple states) or partners with U.S.-based distribution networks.
  • Can show measurable patient impact and need for donated insulin or diabetes supplies.

Geography

Broad

Observed grants in the latest year were distributed to organizations in 17 states, with roughly 63% of dollars going outside the foundation's home state, indicating a multi-state national footprint rather than purely local giving.

Recipient Variety

Broad

In 2023 the funder supported 38 distinct recipients that include hospitals, university clinics, and nonprofit diabetes programs; while many grantees recur, the portfolio is numerically broad and institutionally diverse in the latest observed year.

New Applicants

Broad

Direct evidence of entry exists: 11 new recipients appeared in 2023 (about 29% of that year's grantees). Although no formal application guidelines were found, the presence of recurring awards plus a substantial share of new grantees across two years suggests unfamiliar applicants can enter the portfolio.

Source: Zeffy Agent · Mar 2026